BioSpace News Archive

Encompass Health Corp. (NYSE: EHC) today announced it will participate in the Barclays Global Healthcare Conference, which is being held in Miami, Florida , on March 14-16, 2023.

ReSuture, Inc, (ReSuture) a dynamic early-stage business developing synthetic training models to expedite adoption of life-saving therapies and medical devices, today announced it has received a $996,413 Small Business Innovation Research (SBIR) grant from the National Science Foundation (NSF).

Pinehurst Surgical Clinic today announced successful completion of the first series of cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, an alternative to spinal fusion surgery.

The Center for Breakthrough Medicines (CBM), a contract development, manufacturing, and testing organization (CDMO) is packaging their pre-clinical capabilities into an IND-enabling offering to help innovator companies manufacture high quality drug substance and drug product for pre-clinical studies needed for IND-enabling activities.

Anton Jorgensen, MD and Ortho San Antonio announced the first cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, as an alternative to lumbar spinal fusion surgery.

Avid Bioservices, Inc. today announced that it will report financial results for the third quarter of fiscal year 2023 on March 13, 2023, after market close and will host a webcast at 1:30 PM Pacific Time (4:30 PM Eastern Time).

SOUTH SAN FRANCISCO, Calif., March 06, 2023 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that the company is scheduled to participate in the following investor conferences: Oppenheimer 33 rd Annual Healthcare Conference: Robert I. Blum, President and Chief Executive Officer, will present virtually on Monday, March 13, 2023 at 10:00 AM Eastern Time. Barclays Global Healthcare Conference: Robert I. Blum, President and Chief Executive Officer, will pa

OrthoPediatrics Corp. a company focused exclusively on advancing the field of pediatric orthopedics, announced it was recently named one of the 2023 Best Places to Work in Indiana.

Starlight Therapeutics Inc., a Lantern subsidiary, will focus exclusively on the clinical development of therapies for CNS (central nervous system) and brain cancers with limited or no effective therapeutic options.

Cardiff Oncology, Inc. today formally introduced the full membership of its Scientific Advisory Board (SAB).